Invesco Ltd. Zymeworks Inc. Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.43 $13,280 - $21,220	-2,856 Reduced 5.26%	51,438 $316,000
Q2 2022 Aug 15, 2022	BUY	$4.82 - $7.7 $37,374 - $59,705	7,754 Added 16.66%	54,294 $288,000
Q1 2022 May 16, 2022	BUY	$6.0 - $16.98 $279,240 - $790,249	46,540 New	46,540 $305,000
Q4 2021 Feb 14, 2022	SELL	$15.19 - $29.33 $149,940 - $289,516	-9,871 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.35 - $37.28 $6,153 - $8,388	225 Added 2.33%	9,871 $287,000
Q2 2021 Aug 17, 2021	BUY	$26.5 - $38.23 $77,830 - $112,281	2,937 Added 43.78%	9,646 $335,000
Q1 2021 May 17, 2021	BUY	$29.83 - $56.81 $200,129 - $381,138	6,709 New	6,709 $212,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $766M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.